Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 4, 2006, Pages

  Granqvist, Anna Björnson ^a   Ebefors, K ^a   Saleem, M A ^b   Mathieson, P W ^b   Haraldsson, B ^a   Nyström, J Sörensson ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Glomerular barrier; Glycosaminoglycan biosynthesis; Puromycin

Indexed keywords

BIGLYCAN; DECORIN; MESSENGER RNA; PUROMYCIN AMINONUCLEOSIDE; STEROID; SYNDECAN 1; VERSICAN;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 33749383547     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00433.2005     Document Type: Article

References (44)

1. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, and Zako M. Functions of cell surface heparan sulfate PG. Annu Rev Biochem 68: 729-777, 1999.
2. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, and Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate PG. Annu Rev Cell Biol 8: 365-393, 1992.
3. Bjornson A, Moses J, Ingemansson A, Haraldsson B, and Sorensson J. Primary human glomerular endothelial cells produce PG and puromycin affects their posttranslational modification. Am J Physiol Renal Physiol 288: F748-F756, 2005.
4. Bolton GR, Deen WM, and Daniels BS. Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. Am J Physiol Renal Physiol 274: F889-F896, 1998.
5. Caulfield JP and Farquhar MG. Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis. Lab Invest 39: 505-512, 1978.
6. David G, Danneels A, Duerr J, Grootjans J, Mertens G, Nackaerts K, Romaris M, Schrurs B, Steinfeld R, and Vekemans S. Heparan sulfate PG. Essential cofactors in receptor-mediated processes with relevance to the biology of the vascular wall. Atherosclerosis 118 Suppl: S57-S67, 1995.
7. Deen WM. What determines glomerular capillary permeability? J Clin Invest 114: 1412-1414, 2004.
8. Filmus J and Selleck SB. Glypicans: PG with a surprise. J Clin Invest 108: 497-501, 2001.
9. Fishman JA and Karnovsky MJ. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am J Pathol 118: 398-407, 1985.
10. Greene DK, Tumova S, Couchman JR, and Woods A. Syndecan-4 associates with alpha-actinin. J Biol Chem 278: 7617-7623, 2003.
11. Groffen AJ, Veerkamp JH, Monnens LA, and van den Heuvel LP. Recent insights into the structure and functions of heparan sulfate PG in the human glomerular basement membrane. Nephrol Dial Transplant 14: 2119-2129, 1999.
12. Groggel GC, Hovingh P, Border WA, and Linker A. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis. Am J Pathol 128: 521-527, 1987.
13. Guasch A and Myers BD. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. J Am Soc Nephrol 4: 1571-1581, 1994.
14. Hamano Y, Grunkemeyer JA, Sudhakar A, Zeisberg M, Cosgrove D, Morello R, Lee B, Sugimoto H, and Kalluri R. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 277: 31154-31162, 2002.
15. Haraldsson B and Sorensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 19: 7-10, 2004.
16. Hjalmarsson C, Ohlson M, and Haraldsson B. Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density. Am J Physiol Renal Physiol 281: F503-F512, 2001.
17. Ina K, Kitamura H, Nakamura M, Ono J, and Takaki R. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study. J Diabetes Complications 5: 173-175, 1991.
18. Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, and Sakai T. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis. Kidney Int 50: 1278-1287, 1996.
19. Iozzo RV. Matrix PG: from molecular design to cellular function. Annu Rev Biochem 67: 609-652, 1998.
20. Jeansson M and Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14: 1756-1765, 2003.
21. Kanwar YS and Farquhar MG. Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81: 137-153, 1979.
22. Kasinath BS, Singh AK, Kanwar YS, and Lewis EJ. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol 255: F590-F596, 1988.
23. Kerjaschki D, Sharkey DJ, and Farquhar MG. Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-1596, 1984.
24. Krishnamurti U, Zhou B, Fan WW, Tsilibary E, Wayner E, Kim Y, Kashtan CE, and Michael A. Puromycin aminonucleoside suppresses integrin expression in cultured glomerular epithelial cells. J Am Soc Nephrol 12: 758-766, 2001.
25. Margolis RU and Margolis RK. Aggrecan-versican-neurocan family PG. Methods Enzymol 245: 105-126, 1994.
26. Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, Soininen R, and Tryggvason K. Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 16: 1703-1710, 2005.
27. Mynderse LA, Hassell JR, Kleinman HK, Martin GR, and Martinez-Hernandez A. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. Lab Invest 48: 292-302, 1983.
28. Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, and Ito S. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. J Lab Clin Med 143: 106 -114, 2004.
29. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, Neville AM, and Jat PS. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci USA 98: 646-651, 2001.
30. Ohlson M, Sorensson J, and Haraldsson B. Glomerular size and charge selectivity in the rat as revealed by FITC-ficoll and albumin. Am J Physiol Renal Physiol 279: F84-F91, 2000.
31. Pyke C, Kristensen P, Ostergaard PB, Oturai PS, and Romer J. Proteoglycan expression in the normal rat kidney. Nephron 77: 461-470, 1997.
32. Raats CJ, van den Born J, Bakker MA, Oppers-Walgreen B, Pisa BJ, Dijkman HB, Assmann KJ, and Berden JH. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 156: 1749-1765, 2000.
33. Rapraeger A, Jalkanen M, and Bernfield M. Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol 103: 2683-2696, 1986.
34. Rostgaard J and Qvortrup K. Sieve plugs in fenestrae of glomerular capillaries-site of the filtration barrier? Cells Tissues Organs 170: 132-138, 2002.
35. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, and Mundel P. A conditionally immortalized human podocyte cell line demonstrating nephrin, and podocin expression. J Am Soc Nephrol 13: 630-638, 2002.
36. Salmivirta M, Lidholt K, and Lindahl U. Heparan sulfate: a piece of information. FASEB J 10: 1270-1279, 1996.
37. Schaefer L, Grone HJ, Raslik I, Robenek H, Ugorcakova J, Budny S, Schaefer RM, and Kresse H. Small PG of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 58: 1557-1568, 2000.
38. Shih NY, Li J, Cotran R, Mundel P, Miner JH, and Shaw AS. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159: 2303-2308, 2001.
39. Sorensson J, Bjornson A, Ohlson M, Ballermann BJ, and Haraldsson B. Synthesis of sulfated PG by bovine glomerular endothelial cells in culture. Am J Physiol Renal Physiol 284: F373-F380, 2003.
40. Sorensson J, Ohlson M, Lindstrom K, and Haraldsson B. Glomerular charge selectivity for horseradish peroxidase and albumin at low and normal ionic strengths. Acta Physiol Scand 163: 83-91, 1998.
41. Tryggvason K and Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10: 543-549, 2001.
42. Vink H and Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285-H289, 2000.
43. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14: 617-623, 2002.
44. Zimmermann DR, Dours-Zimmermann MT, Schubert M, and Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 124: 817-825, 1994.